294 related articles for article (PubMed ID: 1782953)
1. Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: results from 1318 cases.
Beaumont V; Lemort N; Beaumont JL
Eur Heart J; 1991 Nov; 12(11):1219-24. PubMed ID: 1782953
[TBL] [Abstract][Full Text] [Related]
2. Smoking and use of oral contraceptives: impact on thrombotic diseases.
Lidegaard O
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
[TBL] [Abstract][Full Text] [Related]
3. [Combined contraceptives and cardiovascular risk].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
[TBL] [Abstract][Full Text] [Related]
4. Residual vascular risk of discontinued oral contraception. Role of antibodies to synthetic sex hormones.
Beaumont V; Lemort N; Doucet F; Beaumont JL
Atherosclerosis; 1985 Dec; 58(1-3):243-59. PubMed ID: 4091881
[TBL] [Abstract][Full Text] [Related]
5. Blood changes in sex steroid hormone users. Circulating immune complexes induced by estrogens and progestogens and their relation to vascular thrombosis.
Beaumont V; Delplanque B; Lemort N; Beaumont JL
Atherosclerosis; 1982 Sep; 44(3):343-53. PubMed ID: 7150397
[TBL] [Abstract][Full Text] [Related]
6. [Vascular complications of oral contraception. In whom and how to prevent them?].
Beaumont V; Lemort N; Beaumont JL
Presse Med; 1983 Dec; 12(47):2977-81. PubMed ID: 6228887
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives.
Beaumont V; Malinow MR; Sexton G; Wilson D; Lemort N; Upson B; Beaumont JL
Atherosclerosis; 1992 Jun; 94(2-3):147-52. PubMed ID: 1632868
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of risk factors associated with vascular thrombosis in women on oral contraceptives. Possible role of anti-sex steroid hormone antibodies.
Beaumont V; Lemort N; Beaumont JL
Artery; 1983; 11(5):331-44. PubMed ID: 6661039
[TBL] [Abstract][Full Text] [Related]
9. [Vascular thrombosis in synthetic estrogen-progestogen users: an immune mechanism (author's transl)].
Beaumont V; Beaumont JL
Nouv Presse Med; 1981 Feb; 10(7):503-7. PubMed ID: 7232196
[TBL] [Abstract][Full Text] [Related]
10. [Stroke and combined oral contraceptives].
Rancurel G; Kieffer E; Buge A
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):137-46. PubMed ID: 12280200
[TBL] [Abstract][Full Text] [Related]
11. [Oral contraception and circulatory risks].
Wingrave SJ
Contracept Fertil Sex (Paris); 1984 Oct; 12(10):1111-6. PubMed ID: 12266560
[TBL] [Abstract][Full Text] [Related]
12. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
Suissa S; Blais L; Spitzer WO; Cusson J; Lewis M; Heinemann L
Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal human immunoglobulin (IgG lambda) with antiethinylestradiol activity, oral contraceptives, and arterial pulmonary thrombosis].
Beaumont JL; Lemort N
C R Acad Hebd Seances Acad Sci D; 1975 Jun; 280(24):2805-8. PubMed ID: 808320
[TBL] [Abstract][Full Text] [Related]
14. Oral contraception, circulating immune complexes, antiethinylestradiol antibodies, and thrombosis.
Beaumont V; Lemort N; Beaumont JL
Am J Reprod Immunol (1980); 1982 Feb; 2(1):8-12. PubMed ID: 7091494
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives: a reassessment.
Derman R
Obstet Gynecol Surv; 1989 Sep; 44(9):662-8. PubMed ID: 2671844
[TBL] [Abstract][Full Text] [Related]
16. Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies.
Girolami A; Zanon E; Zanardi S; Saracino MA; Simioni P
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):497-501. PubMed ID: 8840004
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic diseases in young women and the influence of oral contraceptives.
Lidegaard O
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S62-7. PubMed ID: 9753312
[TBL] [Abstract][Full Text] [Related]
18. Complications and contraindications of oral contraception.
Beck WW
Clin Obstet Gynecol; 1981 Sep; 24(3):893-901. PubMed ID: 7026110
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and the vascular risk of oral contraceptives.
Plowright C; Adam SA; Thorogood M; Beaumont V; Beaumont JL; Mann JI
Br Heart J; 1985 May; 53(5):556-61. PubMed ID: 3994871
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
